A carregar...
Lazarus response to treatment of patients with lung cancer and oncogenic mutations in the intensive care unit
Novel targeted therapy for patients with non-small-cell lung cancer (NSCLC) and oncogenic mutations along with poor performance status (PS) sometimes evokes a “Lazarus” response. Moreover, for critically ill patients with NSCLC and respiratory failure requiring mechanical ventilation (MV) in the int...
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5179459/ https://ncbi.nlm.nih.gov/pubmed/28066630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2016.11.110 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|